Our Management Team
Peter Hamer, CEO
Peter has over 25 years international commercial experience, has held a number of senior leadership positions within the orthopaedic/medical device sector and has been responsible for early stage product development, marketing and international sales and distribution in the fields of sports medicine, regenerative medicine and orthopaedics. He worked at Biomet for 20 years in a number of senior roles, including VP Sports Medicine EMEA and with Corin Group as International Sales Director. More recently in the field of regenerative medicine he served as Global Commercial Director, Orthopaedics at Tissue Regenix. Peter brings a deep and current understanding of the global industry that is the focus of SurgaColl’s business.
Paul Bielderman, Medical Director
Paul has a long heritage as a physician in the medical industry and has worked in both devices and pharma in a range of Medical Affairs and Medical Director roles, including Covidien (now Medtronic), Kyphon (now Medtronic) and Pfizer.
He has a MD, is a specialist Paediatrician, a PhD in Medicine, MBA, BSc and both FARCP and MICR.
Paul’s focus is on the clinical interface and is accountable for medical compliance and vigilance along with a role in designing and executing the company’s Clinical Evidence Programme.
Stephen Cook, Clinical Research Associate
Stephen is an accomplished and experienced Clinical Research leader with 18 years of working experience, encompassing Medical Devices and Pharma.
He has a very strong understanding and insight of processes in the NHS and has led and conducted a range of Clinical Trials in a wide variety or product categories from Cardiology to Orthopedics,
Frank Coombes, CFO
Frank has over 15 years experience in corporate finance, gained both in industry and professional practice. He has held various senior executive finance positions with the “top five” corporate finance consultancies as well as a variety of start-up companies. He has extensive experience of company acquisitions, disposals and fund raising.
Brian Duffy, Operations Director
Brian has great experience in the medical industry and has worked for Abbott, Medtronic and Boston Scientific in senior operational roles and has led significant projects.
Brian is an ASQ certified Six Sigma black belt practitioner, has a B Eng from Limerick University and an MBA from the Open University.
Dr John Gleeson, CTO
John was previously Business Development Manager in the Tissue Engineering Research Group in the Royal College of Surgeons in Ireland. He is an inventor of the technologies and a Principal Investigator/Honorary Research Fellow within RCSI, where as head of the Cartilage Advanced Regenerative Therapies (CART) group, he was responsible for over €2.5 million research funding in the fields of Tissue Engineering and Translational Research. He has a PhD in bioengineering from Trinity College Dublin and an MSc in Leadership & Management from RCSI.
John Hoare, Quality/Regulatory Affairs Manager
John is a highly experienced quality and regulatory affairs leader. He joined us from Bausch and Lomb in Waterford and was previously Regulatory Affairs Manager at GSK for a range of devices and OTC products.
John has extensive executive experience in all aspects of regulatory body engagement, including site preparation, documentation compilation & submission, and post market product registration activities. With a strong quality and regulatory background in devices John also brings pharma experience to the team.
He has a degree in Chemistry from the University of Reading and is based in the Dublin office.
Greg Stirling, Finance & Administration Manager
Greg has a very strong background in Operational Finance and his most recent role was Head of Finance at Venn Digital.
He has a BA in Business Management and Finance and ACCA, is married and lives in Knutsford. He is based in the Alderley Park Office in Cheshire.